These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24842474)

  • 1. The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients.
    Hites M; Dell'Anna AM; Scolletta S; Taccone FS
    Adv Drug Deliv Rev; 2014 Nov; 77():12-21. PubMed ID: 24842474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Pharmacology Studies in Critically Ill Children.
    Thakkar N; Salerno S; Hornik CP; Gonzalez D
    Pharm Res; 2017 Jan; 34(1):7-24. PubMed ID: 27585904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation.
    Jamal JA; Economou CJ; Lipman J; Roberts JA
    Curr Opin Crit Care; 2012 Oct; 18(5):460-71. PubMed ID: 22820155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of continuous renal replacement therapy on drug therapy.
    Susla GM
    Clin Pharmacol Ther; 2009 Nov; 86(5):562-5. PubMed ID: 19727069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.
    Ha MA; Sieg AC
    Pharmacotherapy; 2017 Feb; 37(2):221-235. PubMed ID: 27931091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic principles and drug-dosing adjustments during continuous renal replacement therapies (CRRT)].
    Morabito S; Guzzo I; Vitaliano E; Muzi L; Solazzo A; Pistolesi V; Pierucci A
    G Ital Nefrol; 2006; 23 Suppl 36():S127-38. PubMed ID: 17068740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review.
    Himebauch AS; Kilbaugh TJ; Zuppa AF
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1133-42. PubMed ID: 27322360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Multiple Organ Support Therapy to Extracorporeal Organ Support in Critically Ill Patients.
    Ronco C; Ricci Z; Husain-Syed F
    Blood Purif; 2019; 48(2):99-105. PubMed ID: 31030203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics in critically ill patients.
    Varghese JM; Roberts JA; Lipman J
    Curr Opin Anaesthesiol; 2010 Aug; 23(4):472-8. PubMed ID: 20489605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal organ support (ECOS) in critical illness and acute kidney injury: from native to artificial organ crosstalk.
    Husain-Syed F; Ricci Z; Brodie D; Vincent JL; Ranieri VM; Slutsky AS; Taccone FS; Gattinoni L; Ronco C
    Intensive Care Med; 2018 Sep; 44(9):1447-1459. PubMed ID: 30043276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical advances in renal replacement therapy.
    Ricci Z; Ronco C
    Semin Dial; 2011; 24(2):138-41. PubMed ID: 21517978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients.
    Doig CJ; Sutherland LR; Sandham JD; Fick GH; Verhoef M; Meddings JB
    Am J Respir Crit Care Med; 1998 Aug; 158(2):444-51. PubMed ID: 9700119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and antimicrobial dosing adjustment in critically ill patients during continuous renal replacement therapy.
    Kuang D; Verbine A; Ronco C
    Clin Nephrol; 2007 May; 67(5):267-84. PubMed ID: 17542336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Continuous Renal Replacement Therapies to Multiple Organ Support Therapy.
    Ricci Z; Romagnoli S; Ronco C; La Manna G
    Contrib Nephrol; 2018; 194():155-169. PubMed ID: 29597227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
    Hahn J; Choi JH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous renal replacement therapy in children with multiple organ dysfunction syndrome: a case series.
    Zhang YL; Hu WP; Zhou LH; Wang Y; Cheng A; Shao SN; Hong LL; Chen QY
    Int Braz J Urol; 2014; 40(6):846-52. PubMed ID: 25615255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drugs dosing in intensive care unit during continuous renal replacement therapy].
    Bourquin V; Ponte B; Saudan P; Martin PY
    Nephrol Ther; 2009 Nov; 5(6):533-41. PubMed ID: 19369134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Veno-Venous Extracorporeal Membrane Oxygenation for Continuous Renal Replacement in a Neonate with Propionic Acidemia.
    Gander JW; Rhone ET; Wilson WG; Barcia JP; Sacco MJ
    J Extra Corpor Technol; 2017 Mar; 49(1):64-66. PubMed ID: 28298669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Echinocandins in a critically ill patient during continuous venovenous renal replacement].
    Aguilar G; Carbonell JA; Ferrando C; Badenes R; Belda FJ
    Rev Iberoam Micol; 2012; 29(2):85-9. PubMed ID: 22463783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.
    Roberts DJ; Hall RI
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1067-84. PubMed ID: 23682923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.